CYTK Cytokinetics, Incorporated - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 6, 2026
$65.60
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$54.3052w निम्न
$88.3152w उच्च
मार्केट कैप
$8.07B
P/E (TTM)
-9.1
EPS (TTM)
$-7.23
राजस्व (TTM)
$68M
आपके बैज
52W रेंज
$54–$88
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$110
P/E
-9.1
ROE
329.8%
शुद्ध लाभ मार्जिन
-1321.1%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
CYTK स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$65.60
मार्केट कैप
$8.07B
P/E (TTM)
-9.1
EPS (TTM)
$-7.23
राजस्व (TTM)
$68M
ROE (TTM)
329.8%
D/E ऋण/इक्विटी (MRQ)
-1.6
52W रेंज
$54–$88
CYTK स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 25 जून 2013 | 1-for-6 | रिवर्स |
Cytokinetics, Incorporated - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
History
Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.
Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based on cytoskeletal proteins. Eventually, the company narrowed its focus to the mechanics of muscle biology. Cytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases.
In 2004 the company completed its initial public offering (IPO).
In January 2007, Cytokinetics named Robert I. Blum as president and CEO. Prior to this, Blum has been involved in the company since its founding, with roles in business development, corporate development and R&D.
In 2013, Cytokinetics finalized a licensing and discovery deal with Astellas to research treatment for muscle weakness and fatigue.
In July 2020, Ji Xing Pharmaceuticals signed a financing deal with Cytokinetics, which included the rights to commercialize the drug designed to treat hypertrophic cardiomyopathies, aficamten, in China and certain neighboring regions.
Products
Omecamtiv mecarbil is a cardiac muscle activator for the potential treatment of heart failure. In May 2020, omecamtiv mecarbil was granted fast track designation by the FDA for the treatment of chronic HF with reduced ejection fraction. Amgen purchased an option on omecamtiv mecarbil in 2006, and the two companies extended their partnership several times. In June 2013, Cytokinetics and Amgen expanded their licensing deal for omecamtiv mecarbil to include Japan. In November 2020 Amgen elected to terminate the collaboration, effective May 20, 2021, and Cytokinetics regained worldwide rights to develop and commercialize omecamtiv mecarbil.
Reldesemtiv (previously known as CK-2127107) is a next-generation fast skeletal muscle troponin activator (FSTA) that has undergone clinical trials for ALS.
Aficamten (previously known as CK-3773274) is an oral, small-molecule myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM).
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी673
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$88M2016-12-31 → 2025-12-31
EPS$-6.542016-12-31 → 2025-12-31
फ्री कैश फ्लो$-535M2016-12-31 → 2025-12-31
शुद्ध मार्जिन-1321.1%2016-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | CYTK | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -9.15Y औसत ≈-12.2 | ≈-12.2 | · | · | |
| P/S | 91.65Y औसत ≈323.5 | ≈323.5 | 41.9 | अति मूल्यांकित | |
| P/B | -12.25Y औसत ≈-19.9 | ≈-19.9 | · | · | |
| EV / EBITDA | -13.75Y औसत ≈-15.1 | ≈-15.1 | · | · | |
| Price / FCF (मूल्य / FCF) | -15.15Y औसत ≈-16.6 | ≈-16.6 | · | · | |
| Price / Cash Flow (मूल्य / नकदी प्रवाह) | -15.85Y औसत ≈-18.3 | ≈-18.3 | · | · | |
| EV / Revenue (EV / राजस्व) | 93.55Y औसत ≈322.6 | ≈322.6 | · | · | |
| EV / FCF | -15.45Y औसत ≈-16.6 | ≈-16.6 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | CYTK | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | -1046.1%5Y औसत ≈-2159.0% | ≈-2159.0% | -118.4% | कमजोर | |
| EBITDA मार्जिन (TTM) | -1027.6%5Y औसत ≈-2113.0% | ≈-2113.0% | -118.4% | कमजोर | |
| शुद्ध लाभ मार्जिन (TTM) | -1321.1%5Y औसत ≈-2357.7% | ≈-2357.7% | -176.2% | कमजोर | |
| ROA (TTM) | -56.8%5Y औसत ≈-47.8% | ≈-47.8% | -22.9% | कमजोर | |
| ROE (TTM) | 329.8%5Y औसत ≈322.1% | ≈322.1% | -13.2% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | CYTK | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | -1.65Y औसत ≈-0.4 | ≈-0.4 | 0.3 | कम ऋण | |
| वर्तमान अनुपात (MRQ) | 6.75Y औसत ≈6.7 | ≈6.7 | 5.9 | अनुरूप | |
| Quick Ratio (त्वरित अनुपात) | 0.75Y औसत ≈1.1 | ≈1.1 | 3.6 | कम तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | -1.45Y औसत ≈-0.3 | ≈-0.3 | · | · | |
| Interest Coverage (ब्याज कवरेज) | -13.45Y औसत ≈-14.6 | ≈-14.6 | -7.7 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | CYTK | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 376.6%5Y औसत ≈98.1% | ≈98.1% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | -2.4%5Y औसत ≈-29.0% | ≈-29.0% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 9.5% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | CYTK | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.15Y औसत ≈0.1 | ≈0.1 | 0.2 | कमजोर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 5.15Y औसत ≈4.8 | ≈4.8 | 5.7 | अनुरूप | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$130.8K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-4.4%
अगली रिपोर्ट
नव 03, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 5, 2026 | $-1.50 | $-1.67 | 10.4% |
| 31 मार्च 2026 | $-1.67 | $-1.69 | 0.94% | |
| 31 दिसमबर 2025 | $-1.50 | $-1.49 | -0.97% | |
| 30 सितमबर 2025 | $-2.55 | $-1.61 | -58.2% | |
| 30 जून 2025 | $-1.12 | $-1.41 | 20.3% | |
| 31 मार्च 2025 | $-1.39 | $-1.41 | 1.4% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| R&D Expense | $416M | $339M | $330M | $241M | $160M | $97M | $86M | $89M | $90M | $60M | $46M | $44M | |
| SG&A Expense | $284M | $215M | $174M | $178M | $97M | $53M | $40M | $31M | $36M | $28M | $20M | $17M | |
| Operating Expenses | $700M | $555M | $504M | $419M | $257M | $150M | $126M | $120M | $127M | $88M | $66M | $62M | |
| Operating Income | $-612M | $-536M | $-496M | $-324M | $-186M | $-94M | $-99M | $-89M | $-113M | $19M | $-37M | $-15M | |
| Interest Expense | $46M | $38M | $28M | $19M | $16M | $16M | $7M | $4M | $3M | $3M | $268.0K | $0 | |
| Interest Income | · | · | · | $11M | $1M | $5M | $4M | $4M | · | $449.0K | $156.0K | $101.0K | |
| Other Non-op | $48M | $52M | $28M | $11M | $331.0K | $5M | $5M | $4M | $3M | $464.0K | $174.0K | $108.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-106M | $-128M | $16M | $-38M | $-15M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| EPS (Basic) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.41 | $-0.97 | $-0.41 | |
| EPS (Diluted) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.39 | $-0.97 | $-0.41 | |
| Shares (Basic) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 39,943,000 | 38,814,000 | 35,709,000 | |
| Shares (Diluted) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 42,561,000 | 38,814,000 | 35,709,000 | |
| EBITDA | $-602M | $-527M | $-484M | $-318M | $-184M | $-92M | $-98M | $-88M | $-111M | $19M | $-37M | $-14M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $123M | $95M | $113M | $66M | $113M | $83M | $36M | $42M | $125M | $67M | $65M | $20M | |
| Receivables | $18M | $17M | $1M | $147.0K | $52M | $4M | $5M | $2M | $1M | $24.0K | · | · | |
| Inventory | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $15M | $12M | $12M | $12M | $6M | $3M | $2M | $4M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $917M | $1.11B | $628M | $795M | $536M | $474M | $234M | $208M | $274M | $159M | $113M | $131M | |
| PP&E (Net) | $79M | $66M | $69M | $80M | $73M | $13M | $5M | $3M | $4M | $4M | $2M | $2M | |
| PP&E (Gross) | $126M | $103M | $97M | $98M | $89M | $38M | $29M | $27M | $26M | $25M | $23M | $22M | |
| Accum. Depreciation | $47M | $37M | $28M | $17M | $16M | $25M | $24M | $24M | $23M | $21M | $21M | $20M | |
| Other Non-current Assets | $17M | $8M | $8M | $10M | $7M | $6M | · | $300.0K | $429.0K | $200.0K | $200.0K | $200.0K | |
| Total Assets | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Accounts Payable | $22M | $20M | $22M | $26M | $21M | $8M | $8M | $4M | $5M | $4M | $2M | $1M | |
| Accrued Liabilities | $83M | $55M | $43M | $44M | $34M | $19M | $12M | $16M | $17M | $18M | $8M | $5M | |
| Current Liabilities | $202M | $180M | $103M | $85M | $72M | $31M | $26M | $22M | $32M | $33M | $32M | $24M | |
| Capital Leases | $108M | $113M | $120M | $127M | $112M | $440.0K | $2M | $771.0K | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $186.0K | $1M | $4M | $0 | · | $771.0K | $1M | $142.0K | · | · | |
| Total Liabilities | $2.08B | $1.54B | $1.21B | $1.12B | $597M | $420M | $301M | $185M | $185M | $76M | $47M | $41M | |
| Long-term Debt | $288M | $620M | $639M | $650M | · | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Total Debt | $288M | $105M | $68M | $64M | $47M | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Common Stock | $123.0K | $118.0K | $102.0K | $94.0K | $84.0K | $70.0K | $59.0K | $55.0K | $54.0K | $41.0K | $40.0K | $39.0K | |
| Paid-in Capital | · | · | · | · | $1.45B | · | · | · | · | · | · | $589M | |
| Retained Earnings | $-3.49B | $-2.70B | $-2.11B | $-1.59B | $-1.21B | $-992M | $-865M | $-743M | $-646M | $-518M | $-535M | $-497M | |
| AOCI | $630.0K | $2M | $-10.0K | $-4M | $-869.0K | $149.0K | $679.0K | $500.0K | $343.0K | $137.0K | $149.0K | $-4.0K | |
| Stockholders' Equity | $-660M | $-135M | $-386M | $-108M | $244M | $113M | $-11M | $26M | $110M | $94M | $69M | $92M | |
| Liabilities + Equity | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Shares Outstanding | 122,943,172 | 118,209,139 | 101,637,922 | 94,833,975 | 84,799,542 | 71,015,183 | 59,172,124 | 54,717,906 | 53,960,832 | 40,646,595 | 39,581,692 | 38,659,738 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $10M | $12M | $6M | $2M | $2M | $1M | $1M | $2M | $741.0K | $589.0K | $490.0K | |
| Stock-based Comp | $112M | $98M | $72M | $48M | $27M | $18M | $11M | $10M | $9M | $7M | $5M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $153M | $86M | $28M | $36M | $44M | $117M | $19M | $-6M | $15M | $13M | $37M | $-34M | |
| Operating Cash Flow | $-510M | $-396M | $-414M | $-300M | $-143M | $9M | $-91M | $-101M | $-102M | $37M | $5M | $-45M | |
| CapEx | $25M | $4M | $1M | $11M | $49M | $11M | $3M | $889.0K | $3M | $2M | $562.0K | $1M | |
| Investing Cash Flow | $17M | $-553M | $239M | $-262M | $-148M | $-197M | $-75M | $5M | $-66M | · | · | · | |
| Net Debt Issued | $-11M | $-9M | · | $-48M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Net Stock Activity | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Financing Cash Flow | $524M | $931M | $221M | $516M | $320M | $234M | $160M | $13M | $226M | · | · | · | |
| Net Change in Cash | $30M | $-18M | $46M | $-45M | $30M | $47M | $-6M | $-83M | $58M | $2M | $45M | $57.0K | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-535M | $-400M | $-416M | $-311M | $-191M | $-2M | $-94M | $-102M | $-105M | $35M | $4M | $-46M | |
| Levered FCF | · | · | · | · | · | · | · | $-106M | $-108M | $33M | · | $-46M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% | -130.5% | -31.4% | |
| Net Margin | -891.6% | -3191.1% | -6988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| Pretax Margin | · | · | · | · | · | · | · | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| EBITDA Margin | -683.9% | -2851.1% | -6431.8% | -336.6% | -261.3% | -165.0% | -363.2% | -278.3% | -833.9% | 18.3% | -128.5% | -30.4% | |
| ROA | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | |
| ROE | 152.7% | 789.8% | 127.6% | 628.0% | -87.4% | -96.8% | 790.0% | -272.5% | -125.2% | 20.2% | -46.7% | -20.0% | |
| ROIC | · | · | · | · | · | · | · | -130.1% | -80.1% | 15.0% | -44.9% | -16.0% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 | 15.2 | 9.0 | 9.4 | 8.5 | 4.8 | 3.6 | 5.5 | |
| Quick Ratio | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 | 2.8 | 1.6 | 2.0 | 3.9 | 2.0 | 2.1 | 0.8 | |
| Debt / Equity | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.6 | 0.3 | 0.3 | 0.2 | · | |
| LT Debt / Equity | -0.4 | -0.7 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.5 | 0.3 | 0.3 | 0.2 | · | |
| Interest Coverage | -13.4 | -14.2 | -17.5 | -16.7 | -11.3 | -5.9 | -14.9 | -23.4 | -37.6 | 6.9 | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.4 | |
| Receivables Turnover | 5.1 | 2.1 | 10.5 | 3.6 | 2.5 | 11.7 | 7.3 | 18.8 | 23.5 | · | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-5.37 | $-1.15 | $-3.80 | $-1.14 | $2.88 | $1.60 | $-0.18 | $0.47 | $2.04 | $2.32 | $1.73 | $2.38 | |
| Revenue / Share | $733.03 | $164.98 | $78.01 | $1053.03 | · | · | · | · | $0.27 | $2.50 | · | · | |
| Cash Flow / Share | $-4246.43 | $-3535.39 | $-4292.54 | $-3334.44 | · | · | · | · | $-2.06 | $0.87 | · | · | |
| Cash / Share | $1.00 | $0.80 | $1.11 | $0.69 | $1.33 | $1.17 | $0.62 | $0.77 | $2.32 | $1.65 | $1.64 | $0.52 | |
| EPS (TTM) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.39 | $-0.97 | $-0.41 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 376.6% | 145.3% | -92.0% | 34.3% | 26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -36.0% | -48.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| Net Income TTM | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| Market Cap | $7.81B | $5.56B | $8.49B | $4.35B | $3.87B | $1.48B | $628M | $346M | $440M | $494M | $414M | $310M | |
| Enterprise Value | $7.98B | $5.57B | $8.44B | $4.34B | $3.80B | $1.44B | $636M | $346M | $346M | $457M | $364M | · | |
| P/E | -9.7 | -8.9 | -15.3 | -10.6 | -16.3 | -10.5 | · | · | -3.1 | 31.2 | -10.8 | -19.5 | |
| P/S | 88.7 | 301.0 | 1126.9 | 45.9 | 54.9 | 26.4 | 23.4 | 11.0 | 32.9 | 4.6 | 14.4 | 6.6 | |
| P/B | -11.8 | -41.1 | -22.0 | -40.3 | 15.8 | 13.0 | -57.4 | 13.3 | 4.0 | 5.2 | 6.0 | 3.4 | |
| P / Tangible Book | · | · | · | · | 15.8 | 13.0 | · | · | · | · | · | · | |
| P / Cash Flow | -15.3 | -14.0 | -20.5 | -14.5 | -27.1 | 165.0 | -6.9 | -3.4 | -4.3 | 13.4 | 84.8 | -6.9 | |
| P / FCF | -14.6 | -13.9 | -20.4 | -14.0 | -20.2 | -699.7 | -6.7 | -3.4 | -4.2 | 14.0 | 95.8 | -6.7 | |
| EV / EBITDA | -13.2 | -10.6 | -17.4 | -13.6 | -20.6 | -15.6 | -6.5 | -3.9 | -3.1 | 23.5 | -9.9 | · | |
| EV / FCF | -14.9 | -13.9 | -20.3 | -14.0 | -19.9 | -682.3 | -6.8 | -3.4 | -3.3 | 12.9 | 84.1 | · | |
| EV / Revenue | 90.6 | 301.5 | 1121.0 | 45.9 | 54.0 | 25.8 | 23.7 | 11.0 | 25.9 | 4.3 | 12.7 | · | |
| Earnings Yield | -10.3% | -11.2% | -6.5% | -9.4% | -6.1% | -9.5% | · | · | -31.8% | 3.2% | -9.3% | -5.1% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $19M | $18M | $2M | $67M | $2M | $17M | $463.0K | $249.0K | $835.0K | $2M | $378.0K | $867.0K | $5M | $2M | $3M | |
| R&D Expense | $98M | $96M | $104M | $99M | $110M | $98M | $94M | $85M | $80M | $82M | $85M | $83M | $83M | $79M | $75M | $63M | |
| SG&A Expense | $104M | $105M | $92M | $69M | $66M | $57M | $62M | $57M | $51M | $46M | $44M | $40M | $40M | $50M | $54M | $48M | |
| Operating Expenses | $208M | $203M | $196M | $169M | $178M | $157M | $156M | $141M | $130M | $127M | $129M | $123M | $123M | $129M | $129M | $111M | |
| Operating Income | $-179M | $-184M | $-178M | $-167M | $-112M | $-156M | $-139M | $-141M | $-130M | $-126M | $-127M | $-122M | $-122M | $-124M | $-127M | $-108M | |
| Interest Expense | · | · | $14M | $11M | $11M | · | $9M | $9M | $13M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Other Non-op | $14M | $11M | $11M | $10M | $13M | $14M | $15M | $17M | $12M | $8M | $8M | $7M | $7M | $6M | $6M | $4M | |
| Net Income | $-199M | $-206M | $-183M | $-306M | $-134M | $-161M | $-150M | $-161M | $-143M | $-136M | $-137M | $-129M | $-129M | $-131M | $-137M | $-142M | |
| EPS (Basic) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| EPS (Diluted) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| Shares (Basic) | 132,086 | 123,273 | · | 119,982 | 119,457 | 118,496 | · | 117,685 | 109,240 | 101,924 | · | 96,071 | 95,755 | 95,164 | · | 93,758 | |
| Shares (Diluted) | 132,086 | 123,273 | · | 119,982 | 119,457 | 118,496 | · | 117,685 | 109,240 | 101,924 | · | 96,071 | 95,755 | 95,164 | · | 93,758 | |
| EBITDA | $-179M | $-180M | · | $-167M | $-112M | $-153M | · | $-141M | $-130M | $-124M | · | $-122M | $-122M | $-123M | · | $-108M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $255M | $130M | $123M | $225M | $75M | $74M | $95M | $47M | $190M | $120M | · | $100M | $69M | $102M | · | $106M | |
| Receivables | $24M | $7M | $18M | $2M | $8M | $2M | $17M | $244.0K | $0 | $834.0K | · | $2M | $985.0K | $1M | · | $2M | |
| Inventory | $380.0K | $154.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $18M | $14M | $17M | $13M | $20M | $16M | $15M | $7M | $11M | $19M | · | $20M | $20M | $16M | · | $14M | |
| Current Assets | $1.21B | $839M | $917M | $977M | $887M | $956M | $1.11B | $1.02B | $1.07B | $639M | · | $561M | $587M | $681M | · | $884M | |
| PP&E (Net) | $79M | $82M | $79M | $76M | $70M | $67M | $66M | $64M | $66M | $68M | · | $76M | $77M | $79M | · | $80M | |
| PP&E (Gross) | · | · | $126M | · | · | · | $103M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $37M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $19M | $18M | $17M | $17M | $15M | $13M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | · | |
| Total Assets | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Accounts Payable | $21M | $25M | $22M | $22M | $16M | $14M | $20M | $12M | $9M | $13M | · | $14M | $13M | $17M | · | $14M | |
| Accrued Liabilities | $77M | $69M | $83M | $62M | $52M | $43M | $55M | $50M | $40M | $40M | · | $33M | $31M | $36M | · | $40M | |
| Current Liabilities | $181M | $199M | $202M | $142M | $131M | $160M | $180M | $110M | $103M | $89M | · | $78M | $66M | $75M | · | $76M | |
| Capital Leases | $102M | $105M | $108M | $111M | $111M | $113M | $113M | $115M | $117M | $119M | · | $122M | $124M | $125M | · | $114M | |
| Other Non-current Liabilities | · | · | · | $2M | $2M | $3M | · | $0 | $0 | $2.0K | · | $408.0K | $625.0K | $837.0K | · | $1M | |
| Total Liabilities | $2.10B | $2.10B | $2.08B | $1.96B | $1.59B | $1.53B | $1.54B | $1.45B | $1.42B | $1.20B | · | $1.18B | $1.11B | $1.12B | · | $1.09B | |
| Long-term Debt | $276M | $292M | $288M | $1.00B | $610M | $610M | $105M | $620M | $629M | $630M | · | · | · | · | · | · | |
| Total Debt | $276M | $292M | · | $176M | $173M | $105M | · | $105M | $104M | $68M | · | $61M | $62M | $64M | · | $64M | |
| Common Stock | $138.0K | $124.0K | $123.0K | $122.0K | $119.0K | $119.0K | $118.0K | $118.0K | $117.0K | $105.0K | · | $94.0K | $94.0K | $94.0K | · | $93.0K | |
| Retained Earnings | $-3.89B | $-3.69B | $-3.49B | $-3.30B | $-3.00B | $-2.86B | $-2.70B | $-2.55B | $-2.39B | $-2.25B | · | $-1.98B | $-1.85B | $-1.72B | · | $-1.45B | |
| AOCI | $-4M | $-2M | $630.0K | $34.0K | $-158.0K | $2M | $2M | $5M | $-1M | $-539.0K | · | $-874.0K | $-1M | $-2M | · | $-6M | |
| Stockholders' Equity | $-173M | $-827M | $-660M | $-521M | $-369M | $-266M | $-135M | $-14M | $109M | $-396M | $-386M | $-439M | $-333M | $-229M | $-108M | $-16M | |
| Liabilities + Equity | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Shares Outstanding | · | · | 122,943,172 | · | · | · | 118,209,139 | · | · | · | · | · | · | · | · | · |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $36M | $30M | $31M | $31M | $28M | $24M | $26M | $25M | $25M | $22M | $19M | $19M | $19M | $15M | $13M | $13M | |
| Other Non-cash | · | $27M | · | · | · | $4M | · | · | · | $-18M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-160M | $-145M | $-143M | $-108M | $-128M | $-132M | $-66M | $-102M | $-99M | $-130M | $-74M | $-96M | $-122M | $-122M | $-98M | $-84M | |
| CapEx | $4M | $6M | $6M | $9M | $4M | $6M | $1M | $701.0K | $2M | $0 | $77.0K | $220.0K | $717.0K | $402.0K | $3M | $6M | |
| Investing Cash Flow | $-507M | $145M | $-71M | $-71M | $53M | $106M | $111M | $-45M | $-652M | $33M | $-81M | $73M | $82M | $165M | $29M | $-292M | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-705.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $0 | $0 | · | · | · | $94M | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $94M | · | · | · | · | · | · | |
| Financing Cash Flow | $793M | $8M | $111M | $330M | $79M | $5M | $2M | $3M | $821M | $104M | $169M | $54M | $5M | $-7M | $30M | $389M | |
| Net Change in Cash | $125M | $7M | $-103M | $152M | $2M | $-21M | $48M | $-143M | $70M | $7M | $13M | $31M | $-34M | $36M | $-39M | $13M | |
| Free Cash Flow | · | $-151M | · | · | · | $-137M | · | · | · | $-130M | · | · | · | $-123M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -626.0% | -948.7% | · | -8613.4% | -167.0% | -9856.3% | · | -30410.6% | -52277.9% | -15118.0% | · | -32345.2% | -14077.2% | -2698.3% | · | -4311.8% | |
| Net Margin | -694.4% | -1064.5% | · | -15815.0% | -201.3% | -10220.1% | · | -34675.0% | -57557.4% | -16244.7% | · | -34238.6% | -14837.0% | -2846.1% | · | -5658.4% | |
| EBITDA Margin | -626.0% | -931.2% | · | -8613.4% | -167.0% | -9710.6% | · | -30410.6% | -52277.9% | -14838.8% | · | -32345.2% | -14077.2% | -2658.2% | · | -4311.8% | |
| ROA | -12.6% | -16.2% | · | -21.3% | -9.8% | -15.6% | · | -14.8% | -12.4% | -16.0% | · | -14.2% | -16.6% | -15.0% | · | -14.9% | |
| ROE | 73.3% | 37.7% | · | 114.5% | 103.3% | 48.7% | · | 70.9% | 127.6% | 43.4% | · | 56.9% | 116.1% | 232.9% | · | -122.1% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 4.2 | · | 6.9 | 6.8 | 6.0 | · | 9.3 | 10.4 | 7.2 | · | 7.2 | 8.9 | 9.0 | · | 11.6 | |
| Quick Ratio | 1.5 | 0.7 | · | 1.6 | 0.6 | 0.5 | · | 0.4 | 1.9 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.4 | |
| Debt / Equity | -1.6 | -0.4 | · | -0.3 | -0.5 | -0.4 | · | -7.5 | 1.0 | -0.2 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| LT Debt / Equity | -1.4 | -0.3 | · | -0.3 | -0.4 | -0.3 | · | -6.7 | 0.9 | -0.1 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| Interest Coverage | · | · | · | -14.7 | -10.1 | · | · | -15.8 | -10.2 | -17.8 | · | -17.1 | -17.3 | -17.9 | · | -15.9 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.7 | 4.4 | · | 1.9 | 15.9 | 1.1 | · | 0.3 | 0.5 | 0.9 | · | 0.2 | 0.6 | 1.3 | · | 1.7 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $216.71 | $157.01 | · | $16.14 | $558.94 | $13.33 | · | $3.93 | $2.28 | $8.19 | · | $3.93 | $9.05 | $48.47 | · | $26.82 | |
| Cash Flow / Share | · | $-1179.96 | · | · | · | $-1110.73 | · | · | · | $-1270.62 | · | · | · | $-1285.00 | · | · | |
| EPS (TTM) | $-7.23 | $-6.85 | · | $-6.29 | $-5.10 | $-5.29 | · | $-5.38 | $-5.37 | $-5.40 | · | $-5.60 | $-5.77 | $-4.66 | · | $-3.12 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $68M | $106M | · | $87M | $86M | $19M | · | $3M | $3M | $4M | · | $8M | $10M | $98M | · | $148M | |
| Net Income TTM | $-894M | $-830M | · | $-752M | $-606M | $-615M | · | $-576M | $-545M | $-531M | · | $-527M | $-540M | $-431M | · | $-282M | |
| P/E | -11.8 | -9.6 | · | -8.7 | -6.5 | -7.6 | · | -9.8 | -10.1 | -13.0 | · | -5.3 | -5.7 | -7.6 | · | -15.5 | |
| Earnings Yield | -8.5% | -10.4% | · | -11.4% | -15.4% | -13.2% | · | -10.2% | -9.9% | -7.7% | · | -19.0% | -17.7% | -13.2% | · | -6.4% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $88M | $18M | $8M | $95M | $70M |
| परिचालन मार्जिन % | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% |
| शुद्ध आय | $-785M | $-590M | $-526M | $-389M | $-215M |
| तनुकरणित EPS | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 |
| वर्तमान अनुपात | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 |
| त्वरित अनुपात | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-535M | $-400M | $-416M | $-311M | $-191M |
संस्थागत मालिक (13F) 535 फाइलर्स · $13.2B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
535
धारित मूल्य
$13.2B
नई स्थितियाँ
95
बाहर निकली पोजीशन
49
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 95 (-11 पिछली तिमाही की तुलना में) | 49 (-7 पिछली तिमाही की तुलना में) | 238 (+49 पिछली तिमाही की तुलना में) | 113 (-29 पिछली तिमाही की तुलना में) | +10.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $1711838738 | 20094362 | 12.99% | शेयर |
| VANGUARD GROUP INC | $765538243 | 12048131 | 5.81% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $590517486 | 6931770 | 4.48% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $571778157 | 6711799 | 4.34% | शेयर |
| STATE STREET CORP | $553243709 | 6494233 | 4.20% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $521151103 | 6117515 | 3.95% | शेयर |
| FMR LLC | $428657534 | 5031782 | 3.25% | शेयर |
| Avoro Capital Advisors LLC | $425949915 | 4999999 | 3.23% | शेयर |
| BANK OF AMERICA CORP /DE/ | $394916049 | 4635709 | 3.00% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $316325896 | 3712501 | 2.40% | शेयर |
| RTW INVESTMENTS, LP | $243814036 | 2862003 | 1.85% | शेयर |
| Polar Capital Holdings Plc | $191988358 | 2253649 | 1.46% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161060214 | 1890600 | 1.22% | कॉल ऑप्शन |
| GOLDMAN SACHS GROUP INC | $150069725 | 1761588 | 1.14% | शेयर |
| Capital Research Global Investors | $143683584 | 1686625 | 1.09% | शेयर |
| NORTHERN TRUST CORP | $140337319 | 1647345 | 1.06% | शेयर |
| JPMORGAN CHASE & CO | $139150046 | 1588895 | 1.06% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $136597224 | 1603442 | 1.04% | शेयर |
| Integral Health Asset Management, LLC | $136304000 | 1600000 | 1.03% | शेयर |
| Point72 Asset Management, L.P. | $135257185 | 1587712 | 1.03% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $133388883 | 1565781 | 1.01% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $131998327 | 1549458 | 1.00% | शेयर |
| ARMISTICE CAPITAL, LLC | $130340700 | 1530000 | 0.99% | कॉल ऑप्शन |
| MORGAN STANLEY | $128664004 | 1510318 | 0.98% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $111740656 | 1311664 | 0.85% | शेयर |
| Capital International Investors | $111245191 | 1305848 | 0.84% | शेयर |
| Invesco Ltd. | $105237167 | 1235323 | 0.80% | शेयर |
| ARMISTICE CAPITAL, LLC | $102342325 | 1201342 | 0.78% | शेयर |
| UBS Group AG | $99781940 | 1171287 | 0.76% | शेयर |
| Pictet Asset Management Holding SA | $99038455 | 1160463 | 0.75% | शेयर |
| Frazier Life Sciences Management, L.P. | $98810092 | 1159879 | 0.75% | शेयर |
| Bank of New York Mellon Corp | $98027901 | 1150697 | 0.74% | शेयर |
| Holocene Advisors, LP | $97506685 | 1144579 | 0.74% | शेयर |
| Woodline Partners LP | $93769315 | 1100708 | 0.71% | शेयर |
| D. E. Shaw & Co., Inc. | $89287894 | 1048103 | 0.68% | शेयर |
| NORGES BANK | $86512319 | 1015522 | 0.66% | शेयर |
| Royalty Pharma Sub-Manager, LLC | $83519594 | 980392 | 0.63% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $81937000 | 961815 | 0.62% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $77218175 | 906423 | 0.59% | शेयर |
| CITADEL ADVISORS LLC | $77062874 | 904600 | 0.58% | कॉल ऑप्शन |
| FRANKLIN RESOURCES INC | $75911721 | 891087 | 0.58% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $70521134 | 827810 | 0.53% | शेयर |
| Melqart Asset Management (UK) Ltd | $65385455 | 767525 | 0.50% | शेयर |
| Siren, L.L.C. | $64655121 | 758952 | 0.49% | शेयर |
| Fisher Asset Management, LLC | $63355547 | 743697 | 0.48% | शेयर |
| Foresite Capital Management IV, LLC | $60884867 | 714695 | 0.46% | शेयर |
| Balyasny Asset Management L.P. | $60599821 | 711349 | 0.46% | शेयर |
| Deep Track Capital, LP | $59633000 | 700000 | 0.45% | शेयर |
| JANE STREET GROUP, LLC | $59633000 | 700000 | 0.45% | कॉल ऑप्शन |
| BNP PARIBAS FINANCIAL MARKETS | $58702470 | 689077 | 0.45% | शेयर |
कंपनी के अंदरूनी सूत्र 52 इनसाइडर्स · 19 अधिकारी · 23 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Robert I Blum | President & CEO | 28 सितमबर 2026 M | 278544 | 0 | 20 | $-17291957 |
| Sung Lee | EVP, Chief Financial Officer | 1 जुलाई 2026 M | 63221 | 0 | 5 | $-5695855 |
| Ching Jaw | SVP Finance & CFO | 6 मार्च 2023 A | 87346 | 0 | 0 | $0 |
| Sharon Surrey Barbari | EVP, Finance & CFO | 28 फ़रवरी 2017 F | 40323 | 0 | 0 | $0 |
| Fady Ibraham Malik | EVP Research & Development | 22 सितमबर 2026 M | 153902 | 0 | 21 | $-4654735 |
| Andrew Callos | EVP, Chief Commercial Officer | 31 अगस्त 2026 M | 58555 | 0 | 25 | $-16021293 |
| Jeffrey Hessekiel | Chief Legal & Admin Officer | 15 मार्च 2026 A | 107943 | 0 | 0 | $0 |
| Robert Wong | VP, Chief Accounting Officer | 3 दिसमबर 2024 A | 18655 | 0 | 0 | $0 |
| Brett A Pletcher | EVP, Chief Legal Officer | 30 अगस्त 2024 A | 33140 | 0 | 0 | $0 |
| Mark A Schlossberg | SVP - Legal & General Counsel | 15 मार्च 2022 M | 103408 | 0 | 0 | $0 |
| David Cragg | Chief HR & Admin Officer | 7 मार्च 2022 F | 153233 | 0 | 0 | $0 |
| Caryn Gordon Mcdowell | GC & Chief Compliance Officer | 27 फ़रवरी 2018 A | 32548 | 0 | 0 | $0 |
| Peter S Roddy | SVP Finance & CAO | 27 फ़रवरी 2018 A | 21520 | 0 | 0 | $0 |
| Bradley Paul Morgan | SVP Drug Discovery & Early Dev | 31 अगस्त 2017 M | 46441 | 0 | 0 | $0 |
| Bonnie Charpentier | SVP Regulatory & Compliance | 28 फ़रवरी 2017 A | 29004 | 0 | 0 | $0 |
| Andrew A Wolff | SVP & CMO | 28 फ़रवरी 2017 A | 47255 | 0 | 0 | $0 |
| David J Morgans JR | EVP-Preclinical R&D | 28 फ़रवरी 2011 A | 42000 | 0 | 0 | $0 |
| Michael Rabson | SVP Business Dev/Legal & GC | 18 दिसमबर 2009 M | 20043 | 0 | 0 | $0 |
| Jay K Trautman | VP, Discovery Research | 29 फ़रवरी 2008 A | 47896 | 0 | 0 | $0 |
| Robert E Landry | निदेशक | 15 सितमबर 2026 S | 8184 | 0 | 2 | $-146790 |
| Lynne B Parshall | निदेशक | 1 सितमबर 2026 S | 10784 | 0 | 4 | $-1357500 |
| Robert Arthur Harrington | निदेशक | 15 जुलाई 2026 A | 21932 | 0 | 1 | $-143620 |
| James M Daly | निदेशक | 15 जुलाई 2026 A | 3390 | 0 | 0 | $0 |
| Edward M. Kaye MD | निदेशक | 15 जुलाई 2026 A | 10434 | 0 | 4 | $-2837811 |
| Nancy Wysenski | निदेशक | 15 जुलाई 2026 A | 33992 | 0 | 0 | $0 |
| Wendell Wierenga | निदेशक | 15 जुलाई 2026 A | 35563 | 0 | 3 | $-1881925 |
| John T Henderson | निदेशक | 15 जुलाई 2026 A | 78360 | 0 | 2 | $-2078525 |
| Muna Bhanji | निदेशक | 27 मई 2026 A | 26361 | 0 | 0 | $0 |
| Wendall Wierenga | निदेशक | 15 जुलाई 2025 A | 32345 | 0 | 0 | $0 |
| COSTA SANTO J | निदेशक | 15 मई 2024 A | 20600 | 0 | 0 | $0 |
| Sandford D Smith | निदेशक | 2 जनवरी 2024 A | 18801 | 0 | 0 | $0 |
| Robert Califf | निदेशक | 3 जनवरी 2022 A | 6003 | 0 | 0 | $0 |
| GAGE L PATRICK | निदेशक | 8 नवमबर 2021 M | 28932 | 0 | 0 | $0 |
| Denise Gilbert | निदेशक | 20 मई 2015 J | · | 0 | 0 | $0 |
| Stephen M Dow | निदेशक | 2 जनवरी 2013 A | 1421052 | 0 | 0 | $0 |
| James A Spudich | निदेशक | 18 मई 2011 A | 180600 | 0 | 0 | $0 |
| Grant A Heidrich III | निदेशक | 3 जनवरी 2011 A | 93755 | 0 | 0 | $0 |
| Michael Schmertzler | निदेशक | 3 जून 2010 S | 4340923 | 0 | 0 | $0 |
| Mark Mcdade | निदेशक | 21 मई 2009 A | · | 0 | 0 | $0 |
| Charles J Homcy | निदेशक | 22 मई 2008 A | · | 0 | 0 | $0 |
| William J Rutter | निदेशक | 29 अप्रैल 2004 C | 172413 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VI LP | 10% मालिक | 29 अप्रैल 2004 C | 1615716 | 0 | 0 | $0 |
| SRB ASSOCIATES VIII LP | 10% मालिक | 29 अप्रैल 2004 C | 771052 | 0 | 0 | $0 |
| SRB ASSOCIATES VII LP | 10% मालिक | 29 अप्रैल 2004 C | 650000 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VIII LP | 10% मालिक | 29 अप्रैल 2004 C | 755631 | 0 | 0 | $0 |
| Elisabeth Schnieders | · | 28 फ़रवरी 2017 A | 43919 | 0 | 0 | $0 |
| James H Sabry | · | 3 जून 2010 M | 0 | 0 | 0 | $0 |
| SEVIN ROSEN VII AFFILIATES FUND LP | · | 29 अप्रैल 2004 C | 24050 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VII LP | · | 29 अप्रैल 2004 C | 625950 | 0 | 0 | $0 |
| SRB ASSOCIATES VI LP | · | 29 अप्रैल 2004 C | 1742951 | 0 | 0 | $0 |
| SEVIN ROSEN VIII AFFILIATES FUND LP | · | 29 अप्रैल 2004 C | 15421 | 0 | 0 | $0 |
| SEVIN ROSEN VI AFFILIATES FUND LP | · | 29 अप्रैल 2004 C | 127235 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 54 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.51% | 19346 NS | 31 जुलाई 2026 | N-PORT |
| XMMO · Invesco Exchange-Traded Fund Trust | 0.81% | 882597 SH | 2 अक्टूबर 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.79% | 50312 NS | 31 जुलाई 2026 | N-PORT |
| IBB · iShares Trust | 0.73% | 1020305 SH | 11 सितमबर 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.72% | 53872 NS | 31 जुलाई 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.64% | 107023 NS | 31 जुलाई 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.64% | 102933 SH | 19 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.61% | 9831 SH | 2 अक्टूबर 2026 | दैनिक |
| IQSM · New York Life Investments ETF Trust | 0.35% | 14748 NS | 31 जुलाई 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.34% | 761130 SH | 19 अगस्त 2026 | दैनिक |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.33% | 72343 SH | 19 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.33% | 63327 NS | 31 जुलाई 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.32% | 1797986 SH | 19 अगस्त 2026 | दैनिक |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.32% | 219413 SH | 19 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.32% | 3378753 SH | 11 सितमबर 2026 | दैनिक |
| IVOV · VANGUARD ADMIRAL FUNDS | 0.31% | 53623 SH | 19 अगस्त 2026 | दैनिक |
| ISCG · iShares Trust | 0.30% | 39366 SH | 11 सितमबर 2026 | दैनिक |
| PTMC · Pacer Funds Trust | 0.29% | 14892 NS | 31 जुलाई 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.27% | 48364 NS | 31 जुलाई 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.24% | 20179 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.23% | 88671 SH | 11 सितमबर 2026 | दैनिक |
| MIDU · Direxion Shares ETF Trust | 0.22% | 1994 NS | 31 जुलाई 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.22% | 687 NS | 31 जुलाई 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.22% | 16176 NS | 31 जुलाई 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.21% | 54306 NS | 31 जुलाई 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0.20% | 15469 NS | 31 जुलाई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.19% | 3254 NS | 31 जुलाई 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 40586 SH | 19 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.14% | 3113794 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.14% | 333056 SH | 19 अगस्त 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.13% | 1557779 SH | 19 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 52671 NS | 31 जुलाई 2026 | N-PORT |
| ESSC · Strategy Shares | 0.10% | 466 NS | 31 जुलाई 2026 | N-PORT |
| WSML · iShares Trust | 0.09% | 7841 SH | 11 सितमबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.07% | 15233 SH | 19 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.07% | 133196 SH | 11 सितमबर 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.07% | 27265 SH | 2 अक्टूबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.02% | 5740 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 4315260 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 10880 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.02% | 29174 SH | 19 अगस्त 2026 | दैनिक |
| IUSG · iShares Trust | 0.01% | 64511 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.01% | 53197 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.01% | 180021 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.01% | 36083 SH | 10 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 106638 SH | 19 अगस्त 2026 | दैनिक |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.00% | 478 SH | 29 सितमबर 2026 | दैनिक |
| IJH · iShares Trust | · | 4763860 SH | 11 सितमबर 2026 | दैनिक |
| IJK · iShares Trust | · | 425186 SH | 11 सितमबर 2026 | दैनिक |
| IJJ · iShares Trust | · | 318457 SH | 21 अगस्त 2026 | दैनिक |
| IWN · iShares Trust | · | 1107696 SH | 11 सितमबर 2026 | दैनिक |
| XJH · iShares Trust | · | 18548 SH | 8 सितमबर 2026 | दैनिक |
| ISCB · iShares Trust | · | 5565 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 71881 SH | 11 सितमबर 2026 | दैनिक |
CYTK विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 28 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$107.50
+63.9%
6 21.4%
मजबूत खरीद
19 67.9%
खरीदें
3 10.7%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
20 विश्लेषक · 2026-09-29माध्य लक्ष्य $109.90 +67.5%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $65.60
निम्न$85.00
माध्य$109.90
उच्च$146.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 6, 2026 को फाइल किया गया